ARCHIVES

Talactoferrin Second-Line Therapy Increases Survival In Stage IIIB/IV

This article is from The Cancer Letter archive.

Vol. 34 No. 10 | October 28, 2011

Download PDF Visit The Full Archive

Related Articles

In Brief: Calabresi Named DCT Board Chairman; NCI Gets $5 Million Gifts for Intramural Breast Cancer Work

June 20, 1986

Diet-Nutrition Grant Guidelines: NIH Says They’re CREGS, Gori Says They’re Not

April 9, 1976

CT Scanning Use, Costs, Controls Debated By NCAB

October 7, 1977

Centers Urged To Apply For Comprehensive Status By June 1

February 16, 1990

FDA Urges Moratorium On Sale, Use of Silicone Breast Implants

January 10, 1992

NIH announces The Cancer Genome Atlas, new name for human cancer genome project.

December 16, 2005